QleanAir AB (publ), the premium provider of solutions for clean indoor air, announces winning an order worth 915,000 USD from private drug compounding organization to provide a large cleanroom suite.
QleanAir has won a contract to build a large cleanroom suite from a large private drug compounding organization on the US west coast. The cleanroom suite will consist of sterile and non-sterile spaces and construction will begin and end in Q2 of 2023.
– “While hospital pharmacies continue to be a cornerstone of our business, QleanAir is successfully working its way into new markets to the US business. This is one more step towards becoming a leading cleanroom partner in the US. We feel confident that we will be an excellent partner for this customer’s project and their future expansion projects.”, says Zachary Douglas, President of QleanAir Scandinavia Inc.